尋找研究成果

在所有內容中搜尋

為 研究成果 進行篩選

搜尋概念
已選取的篩選器

出版年份

  • 2020
  • 2019
  • 2018
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011

作者

  • Wu-Chou Su
2011
13 引文 斯高帕斯(Scopus)
35 引文 斯高帕斯(Scopus)

EGFR L858R mutation and polymorphisms of genes related to estrogen biosynthesis and metabolism in never-smoking female lung adenocarcinoma patients

Yang, S. Y., Yang, T. Y., Chen, K. C., Li, Y. J., Hsu, K. H., Tsai, C. R., Chen, C. Y., Hsu, C. P., Hsia, J. Y., Chuang, C. Y., Tsai, Y. H., Chen, K. Y., Huang, M. S., Su, W. C., Chen, Y. M., Hsiung, C. A., Shen, C. Y., Chang, G. C., Yang, P. C. & Chen, C. J., 2011 四月 15, 於 : Clinical Cancer Research. 17, 8, p. 2149-2158 10 p.

研究成果: Article

22 引文 斯高帕斯(Scopus)

Elevated BCRP/ABCG2 Expression Confers Acquired Resistance to Gefitinib in Wild-Type EGFR-Expressing Cells

Chen, Y. J., Huang, W. C., Wei, Y. L., Hsu, S. C., Yuan, P., Lin, H. Y., Wistuba, I. I., Lee, J. J., Yen, C. J., Su, W. C., Chang, K. Y., Chang, W. C., Chou, T. C., Chou, C. K., Tsai, C. H. & Hung, M. C., 2011 六月 29, 於 : PloS one. 6, 6, e21428.

研究成果: Article

60 引文 斯高帕斯(Scopus)

Epidermal growth factor receptor mutation status in stage i lung adenocarcinoma with different image patterns

Hsu, K. H., Chen, K. C., Yang, T. Y., Yeh, Y. C., Chou, T. Y., Chen, H. Y., Tsai, C. R., Chen, C. Y., Hsu, C. P., Hsia, J. Y., Chuang, C. Y., Tsai, Y. H., Chen, K. Y., Huang, M. S., Su, W. C., Chen, Y. M., Hsiung, C. A., Chang, G. C., Chen, C. J. & Yang, P. C., 2011 六月, 於 : Journal of Thoracic Oncology. 6, 6, p. 1066-1072 7 p.

研究成果: Article

34 引文 斯高帕斯(Scopus)

Malignant pleural effusion cells show aberrant glucose metabolism gene expression

Lin, C. C., Chen, L. C., Tseng, V. S., Yan, J. J., Lai, W. W., Su, W. P., Lin, C. H., Huang, C. Y. F. & Su, W. C., 2011 六月 1, 於 : European Respiratory Journal. 37, 6, p. 1453-1465 13 p.

研究成果: Article

17 引文 斯高帕斯(Scopus)

Polymorphisms of MLH1 and MSH2 genes and the risk of lung cancer among never smokers

Lo, Y. L., Hsiao, C. F., Jou, Y. S., Chang, G. C., Tsai, Y. H., Su, W. C., Chen, K. Y., Chen, Y. M., Huang, M. S., Hsieh, W. S., Chen, C. J. & Hsiung, C. A., 2011 六月 1, 於 : Lung Cancer. 72, 3, p. 280-286 7 p.

研究成果: Article

41 引文 斯高帕斯(Scopus)

Triweekly reduced-dose docetaxel combined with cisplatin in recurrent/metastatic head and neck squamous cell carcinoma: A multicenter phase II study

Chang, P. M. H., Tzeng, C. H., Chen, M. H., Tsao, C. J., Su, W. C., Hwang, W. S., Chang, Y. F., Chang, S. Y. & Yang, M. H., 2011 十二月 1, 於 : Cancer Chemotherapy and Pharmacology. 68, 6, p. 1477-1484 8 p.

研究成果: Article

13 引文 斯高帕斯(Scopus)
2012

Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): A phase 2 trial

Yang, J. C. H., Shih, J. Y., Su, W. C., Hsia, T. C., Tsai, C. M., Ou, S. H. I., Yu, C. J., Chang, G. C., Ho, C. L., Sequist, L. V., Dudek, A. Z., Shahidi, M., Cong, X. J., Lorence, R. M., Yang, P. C. & Miller, V. A., 2012 五月 1, 於 : The Lancet Oncology. 13, 5, p. 539-548 10 p.

研究成果: Article

317 引文 斯高帕斯(Scopus)

Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): A phase 2b/3 randomised trial

Miller, V. A., Hirsh, V., Cadranel, J., Chen, Y. M., Park, K., Kim, S. W., Zhou, C., Su, W. C., Wang, M., Sun, Y., Heo, D. S., Crino, L., Tan, E. H., Chao, T. Y., Shahidi, M., Cong, X. J., Lorence, R. M. & Yang, J. C. H., 2012 五月 1, 於 : The Lancet Oncology. 13, 5, p. 528-538 11 p.

研究成果: Article

720 引文 斯高帕斯(Scopus)

Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms

Wang, C. Y., Chen, C. L., Tseng, Y. L., Fang, Y. T., Lin, Y. S., Su, W. C., Chen, C. C., Chang, K. C., Wang, Y. C. & Lin, C. F., 2012 九月 21, 於 : Journal of Biological Chemistry. 287, 39, p. 32512-32524 13 p.

研究成果: Article

45 引文 斯高帕斯(Scopus)

Betulinic acid decreases specificity protein 1 (Sp1) level via increasing the sumoylation of Sp1 to inhibit lung cancer growth

Hsu, T. I., Wang, M. C., Chen, S. Y., Huang, S. T., Yeh, Y. M., Su, W. C., Chang, W. C. & Hung, J. J., 2012 十二月, 於 : Molecular Pharmacology. 82, 6, p. 1115-1128 14 p.

研究成果: Article

46 引文 斯高帕斯(Scopus)
7 引文 斯高帕斯(Scopus)

Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia

Hosgood, H. D., Wang, W. C., Hong, Y. C., Wang, J. C., Chen, K., Chang, I. S., Chen, C. J., Lu, D., Yin, Z., Wu, C., Zheng, W., Qian, B., Park, J. Y., Kim, Y. H., Chatterjee, N., Chen, Y., Chang, G. C., Hsiao, C. F., Yeager, M., Tsai, Y. H. 及其他64, Wei, H., Kim, Y. T., Wu, W., Zhao, Z., Chow, W. H., Zhu, X., Lo, Y. L., Sung, S. W., Chen, K. Y., Yuenger, J., Kim, J. H., Huang, L., Chen, Y. H., Gao, Y. T., Kim, J. H., Huang, M. S., Jung, T. H., Caporaso, N., Zhao, X., Huan, Z., Yu, D., Kim, C. H., Su, W. C., Shu, X. O., Kim, I. S., Bassig, B., Chen, Y. M., Cha, S. I., Tan, W., Chen, H., Yang, T. Y., Sung, J. S., Wang, C. L., Li, X., Park, K. H., Yu, C. J., Ryu, J. S., Xiang, Y., Hutchinson, A., Kim, J. S., Cai, Q., Landi, M. T., Lee, K. M., Hung, J. Y., Park, J. Y., Tucker, M., Lin, C. C., Ren, Y., Perng, R. P., Chen, C. Y., Jin, L., Chen, K. C., Li, Y. J., Chiu, Y. F., Tsai, F. Y., Yang, P. C., Fraumeni, J. F., Seow, A., Lin, D., Zhou, B., Chanock, S., Hsiung, C. A., Rothman, N. & Lan, Q., 2012 七月 1, 於 : Human genetics. 131, 7, p. 1197-1203 7 p.

研究成果: Article

26 引文 斯高帕斯(Scopus)

Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia

Lan, Q., Hsiung, C. A., Matsuo, K., Hong, Y. C., Seow, A., Wang, Z., Hosgood, H. D., Chen, K., Wang, J. C., Chatterjee, N., Hu, W., Wong, M. P., Zheng, W., Caporaso, N., Park, J. Y., Chen, C. J., Kim, Y. H., Kim, Y. T., Landi, M. T., Shen, H. 及其他111, Lawrence, C., Burdett, L., Yeager, M., Yuenger, J., Jacobs, K. B., Chang, I. S., Mitsudomi, T., Kim, H. N., Chang, G. C., Bassig, B. A., Tucker, M., Wei, F., Yin, Z., Wu, C., An, S. J., Qian, B., Lee, V. H. F., Lu, D., Liu, J., Jeon, H. S., Hsiao, C. F., Sung, J. S., Kim, J. H., Gao, Y. T., Tsai, Y. H., Jung, Y. J., Guo, H., Hu, Z., Hutchinson, A., Wang, W. C., Klein, R., Chung, C. C., Oh, I. J., Chen, K. Y., Berndt, S. I., He, X., Wu, W., Chang, J., Zhang, X. C., Huang, M. S., Zheng, H., Wang, J., Zhao, X., Li, Y., Choi, J. E., Su, W. C., Park, K. H., Sung, S. W., Shu, X. O., Chen, Y. M., Liu, L., Kang, C. H., Hu, L., Chen, C. H., Pao, W., Kim, Y. C., Yang, T. Y., Xu, J., Guan, P., Tan, W., Su, J., Wang, C. L., Li, H., Sihoe, A. D. L., Zhao, Z., Chen, Y., Choi, Y. Y., Hung, J. Y., Kim, J. S., Yoon, H. I., Cai, Q., Lin, C. C., Park, I. K., Xu, P., Dong, J., Kim, C., He, Q., Perng, R. P., Kohno, T., Kweon, S. S., Chen, C. Y., Vermeulen, R., Wu, J., Lim, W. Y., Chen, K. C., Chow, W. H., Ji, B. T., Chan, J. K. C., Chu, M., Li, Y. J., Yokota, J., Li, J., Chen, H., Xiang, Y. B., Yu, C. J., Kunitoh, H., Wu, G., Jin, L., Lo, Y. L., Shiraishi, K., Chen, Y. H., Lin, H. C., Wu, T., Wu, Y. L., Yang, P. C., Zhou, B., Shin, M. H., Fraumeni, J. F., Lin, D., Chanock, S. J. & Rothman, N., 2012 十二月, 於 : Nature Genetics. 44, 12, p. 1330-1335 6 p.

研究成果: Article

197 引文 斯高帕斯(Scopus)
18 引文 斯高帕斯(Scopus)
23 引文 斯高帕斯(Scopus)
10 引文 斯高帕斯(Scopus)
81 引文 斯高帕斯(Scopus)
52 引文 斯高帕斯(Scopus)
155 引文 斯高帕斯(Scopus)

Sp1 expression regulates lung tumor progression

Hsu, T. I., Wang, M. C., Chen, S. Y., Yeh, Y. M., Su, W. C., Chang, W. C. & Hung, J. J., 2012 八月 30, 於 : Oncogene. 31, 35, p. 3973-3988 16 p.

研究成果: Article

81 引文 斯高帕斯(Scopus)

Vinca alkaloids cause aberrant ROS-mediated JNK activation, Mcl-1 downregulation, DNA damage, mitochondrial dysfunction, and apoptosis in lung adenocarcinoma cells

Chiu, W. H., Luo, S. J., Chen, C. L., Cheng, J. H., Hsieh, C. Y., Wang, C. Y., Huang, W. C., Su, W. C. & Lin, C. F., 2012 五月 1, 於 : Biochemical Pharmacology. 83, 9, p. 1159-1171 13 p.

研究成果: Article

68 引文 斯高帕斯(Scopus)
2013

A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer

Ko, A. H., Tempero, M. A., Shan, Y. S., Su, W. C., Lin, Y. L., Dito, E., Ong, A., Wang, Y. W., Yeh, C. G. & Chen, L. T., 2013 八月 20, 於 : British Journal of Cancer. 109, 4, p. 920-925 6 p.

研究成果: Article

110 引文 斯高帕斯(Scopus)

An open-label safety study of first-line bevacizumab in combination with standard chemotherapy in Chinese patients with metastatic colorectal cancer treated in an expanded access program in Taiwan

Lee, K. D., Chen, H. H., Wang, H. M., Tsao, C. J., Hsu, T. C., Chiu, C. F., Su, W. C. & Wang, J. Y., 2013 五月 1, 於 : Oncology (Switzerland). 84, 5, p. 299-304 6 p.

研究成果: Article

2 引文 斯高帕斯(Scopus)

Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study

Hsu, C. H., Kang, Y. K., Yang, T. S., Shun, C. T., Shao, Y. Y., Su, W. C., Sandoval-Tan, J., Chiou, T. J., Jin, K., Hsu, C. & Cheng, A. L., 2013 七月 1, 於 : Oncology (Switzerland). 85, 1, p. 44-52 9 p.

研究成果: Article

34 引文 斯高帕斯(Scopus)

Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy

Chang, C. H., Hsiao, C. F., Yeh, Y-M., Chang, G. C., Tsai, Y. H., Chen, Y. M., Huang, M. S., Chen, H. L., Li, Y. J., Yang, P. C., Chen, C. J., Hsiung, C. A. & Su, W-C., 2013 五月 1, 於 : International Journal of Cancer. 132, 9, p. 1977-1985 9 p.

研究成果: Article

92 引文 斯高帕斯(Scopus)

EGFR exon 19 in-frame deletion and polymorphisms of DNA repair genes in never-smoking female lung adenocarcinoma patients

Yang, S. Y., Yang, T. Y., Li, Y. J., Chen, K. C., Liao, K. M., Hsu, K. H., Tsai, C. R., Chen, C. Y., Hsu, C. P., Hsia, J. Y., Chuang, C. Y., Tsai, Y. H., Chen, K. Y., Huang, M. S., Su, W. C., Chen, Y. M., Hsiung, C. A., Shen, C. Y., Chang, G. C., Yang, P. C. 及其他1, Chen, C. J., 2013 一月 15, 於 : International Journal of Cancer. 132, 2, p. 449-458 10 p.

研究成果: Article

10 引文 斯高帕斯(Scopus)

EGFR polymorphisms, hormone replacement therapy and lung adenocarcinoma risk: Analysis from a genome-wide association study in never-smoking women

Chen, K. Y., Hsiao, C. F., Chang, G. C., Tsai, Y. H., Su, W. C., Chen, Y. M., Huang, M. S., Hsiung, C. A., Chen, C. J. & Yang, P. C., 2013 三月, 於 : Carcinogenesis. 34, 3, p. 612-619 8 p.

研究成果: Article

15 引文 斯高帕斯(Scopus)
14 引文 斯高帕斯(Scopus)

Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokers

Wu, X., Wang, L., Ye, Y., Aakre, J. A., Pu, X., Chang, G. C., Yang, P. C., Roth, J. A., Marks, R. S., Lippman, S. M., Chang, J. Y., Lu, C., Deschamps, C., Su, W. C., Wang, W. C., Huang, M. S., Chang, D. W., Li, Y., Pankratz, V. S., Minna, J. D. 及其他4, Hong, W. K., Hildebrandt, M. A. T., Hsiung, C. A. & Yang, P., 2013 七月 1, 於 : Cancer Research. 73, 13, p. 4028-4038 11 p.

研究成果: Article

36 引文 斯高帕斯(Scopus)
62 引文 斯高帕斯(Scopus)

Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activation

Kwak, E. L., Shapiro, G. I., Cohen, S. M., Becerra, C. R., Lenz, H. J., Cheng, W. F., Su, W. C., Robohn, M., Le Maulf, F., Lobmeyer, M. T., Chand, V. K. & Iafrate, A. J., 2013 六月 18, 於 : Cancer. 119, 16, p. 3043-3051 9 p.

研究成果: Article

16 引文 斯高帕斯(Scopus)

Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations

Sequist, L. V., Yang, J. C. H., Yamamoto, N., O'Byrne, K., Hirsh, V., Mok, T., Geater, S. L., Orlov, S., Tsai, C. M., Boyer, M., Su, W. C., Bennouna, J., Kato, T., Gorbunova, V., Lee, K. H., Shah, R., Massey, D., Zazulina, V., Shahidi, M. & Schuler, M., 2013 九月 20, 於 : Journal of Clinical Oncology. 31, 27, p. 3327-3334 8 p.

研究成果: Article

1875 引文 斯高帕斯(Scopus)
7 引文 斯高帕斯(Scopus)

Randomised clinical trial: Comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma

Shiah, H. S., Chen, C. Y., Dai, C. Y., Hsiao, C. F., Lin, Y. J., Su, W. C., Chang, J. Y., Whang-Peng, J., Lin, P. W., Huang, J. D. & Chen, L. T., 2013 一月 1, 於 : Alimentary Pharmacology and Therapeutics. 37, 1, p. 62-73 12 p.

研究成果: Article

43 引文 斯高帕斯(Scopus)

Risk factors for primary lung cancer among never smokers by gender in a matched case-control study

Lo, Y. L., Hsiao, C. F., Chang, G. C., Tsai, Y. H., Huang, M. S., Su, W. C., Chen, Y. M., Hsin, C. W., Chang, C. H., Yang, P. C., Chen, C. J. & Hsiung, C. A., 2013 三月 1, 於 : Cancer Causes and Control. 24, 3, p. 567-576 10 p.

研究成果: Article

32 引文 斯高帕斯(Scopus)
15 引文 斯高帕斯(Scopus)

Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)

Ramalingam, S., Crawford, J., Chang, A., Manegold, C., Perez-Soler, R., Douillard, J. Y., Thatcher, N., Barlesi, F., Owonikoko, T., Wang, Y., Pultar, P., Zhu, J., Malik, R., Malik Giaccone, R., Della-Fiorentina, S., Begbie, S., Jennens, R., Dass, J., Pittman, K., Ivanova, N. 及其他173, Koynova, T., Petrov, P., Tomova, A., Tzekova, V., Couture, F., Hirsh, V., Burkes, R., Sangha, R., Ambrus, M., Janaskova, T., Musil, J., Novotny, J., Zatloukal, P., Jakesova, J., Klenha, K., Roubec, J., Vanasek, J., Fayette, J., Barlesi, F., Bennouna-Louridi, J., Chouaid, C., Mazières, J., Vallerand, H., Robinet, G., Souquet, P. J., Spaeth, D., Schott, R., Lena, H., Martinet, Y., Kouri, C. E., Baize, N., Scherpereel, A., Molinier, O., Fuchs, F., Josten, K. M., Manegold, C., Marschner, N., Schneller, F., Overbeck, T., Thomas, M., von Pawel, J., Reck Schuette, M., Hagen, V., Schneider, C. P., Georgoulias, V., Varthalitis, I., Zarogoulidis, K., Syrigos, K., Papandreou, C., Bocskei, C., Csanky, E., Juhasz, E., Losonczy, G., Mark, Z., Molnar, I., Papai-Szekely, Z., Tehenes, S., Vinkler, I., Almel, S., Bakshi, A., Bondarde, S., Maru, A., Pathak, A., Pedapenki, R. M., Prasad, K., Prasad, S. V. S. S., Kilara, N., Gorijavolu, D., Deshmukh, C. D., John, S., Sharma, L. M., Amoroso, D., Bajetta, E., Bidoli, P., Bonetti, A., De Marinis, F., Maio, M., Passalacqua, R., Cascinu, S., Bearz, A., Bitina, M., Brize, A., Purkalne, G., Skrodele, M., Baba, A. A., Ratnavelu, K., Saw, M. H., Samson-Fernando, M. C., Ladrera, G. E., Jassem, J., Koralewski, P., Sikorska, L., Serwatowski, P., Krzakowski, M., Cebotaru, C., Filip, D., Ganea-Motan, D. E., Ianuli, C. H., Manolescu, I. G., Udrea, A., Burdaeva, O., Byakhov, M., Filippov, A., Lazarev, S., Mosin, I., Orlov, S., Udovitsa, D., Khorinko, A., Protsenko, S., Chang, A., Lim, H. L., Tan, Y. O., Tan, E. H., Bastus Piulats, R., Garcia-Foncillas, J., Valdivia, J., de Castro, J., Domine Gomez, M., Kim, S. W., Lee, J. S., Kim, H. K., Lee, J. S., Shin, S. W., Kim, D. W., Kim, Y. C., Park, K. C., Chang, C. S., Chang, G. C., Goan, Y. G., Su, W. C., Tsai, C. M., Kuo, H. P., Benekli, M., Demir, G., Gokmen, E., Sevinc, A., Crawford, J., Giaccone, G., Haigentz, M., Owonikoko, T., Agarwal, M., Pandit, S., Araujo, R., Vrindavanam, N., Bonomi, P., Berg, A., Wade, J., Bloom, R., Amin, B., Camidge, R., Hill, D., Rarick, M., Flynn, P., Klein, L., Lo Russo, K., Neubauer, M., Richards, P., Ruxer, R., Savin, M., Weckstein, D., Rosenberg, R., Whittaker, T., Richards Berry, D., Ottensmeier, C., Dangoor, A., Steele, N., Summers, Y., Rankin, E., Rowley, K., Giridharan, S., Kristeleit, H., Humber, C. & Taylor, P., 2013 十一月, 於 : Annals of Oncology. 24, 11, p. 2875-2880 6 p., mdt371.

研究成果: Article

33 引文 斯高帕斯(Scopus)
14 引文 斯高帕斯(Scopus)
11 引文 斯高帕斯(Scopus)
2014

A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

Chao, Y., Hsieh, J. S., Yeh, H. T., Su, Y. C., Wu, C. C., Chen, J. S., Tai, C. J., Bai, L. Y., Yeh, K. H., Su, W. C. & Li, C. P., 2014 四月, 於 : Cancer Chemotherapy and Pharmacology. 73, 4, p. 799-806 8 p.

研究成果: Article

9 引文 斯高帕斯(Scopus)

An open-label, single-arm, phase 2 trial of the polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer

Stadler, W. M., Vaughn, D. J., Sonpavde, G., Vogelzang, N. J., Tagawa, S. T., Petrylak, D. P., Rosen, P., Lin, C. C., Mahoney, J., Modi, S., Lee, P., Ernstoff, M. S., Su, W. C., Spira, A., Pilz, K., Vinisko, R., Schloss, C., Fritsch, H., Zhao, C. & Carducci, M. A., 2014 一月 1, 於 : Cancer. 120, 7, p. 976-982 7 p.

研究成果: Article

61 引文 斯高帕斯(Scopus)

A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies

Lin, C. C., Su, W. C., Yen, C. J., Hsu, C. H., Su, W. P., Yeh, K. H., Lu, Y. S., Cheng, A. L., Huang, D. C. L., Fritsch, H., Voss, F., Taube, T. & Yang, J. C. H., 2014 五月 13, 於 : British Journal of Cancer. 110, 10, p. 2434-2440 7 p.

研究成果: Article

49 引文 斯高帕斯(Scopus)

CDKN1A-mediated responsiveness of MLL-AF4-positive acute lymphoblastic leukemia to Aurora kinase-A inhibitors

Chen, Y. P., Lin, H. J., Chen, J. S., Tsai, M. Y., Hsieh, H. P., Chang, J. Y., Chen, N. F., Chang, K. C., Huang, W. T., Su, W. C., Yang, S. T., Chang, W. C., Hung, L. Y. & Chen, T. Y., 2014 八月 1, 於 : International Journal of Cancer. 135, 3, p. 751-762 12 p.

研究成果: Article

5 引文 斯高帕斯(Scopus)
9 引文 斯高帕斯(Scopus)
10 引文 斯高帕斯(Scopus)